Endothelial progenitor cells (EPCs) may be recruited from the bone marrow to sites of tissue regeneration to sustain neovascularization and reendothelialization after acute vascular injury. This feature makes them particularly suitable for cell-based therapy. In mature endothelium, store-operated Ca 2+ entry (SOCE) is activated following emptying of inositol-1,4,5-trisphosphate-sensitive stores, which controls a wide number of functions, including proliferation, nitric oxide synthesis, and vascular permeability. The present work aimed at investigating SOCE expression in EPCs harvested from both peripheral blood (PB-EPCs) and umbilical cord blood (UCB-EPCs) by employing both Ca 2+ imaging and molecular biology techniques. SOCE was induced upon either pharmacological (ie, cyclopiazonic acid) or physiological (ie, ATP) depletion of the intracellular Ca 2+ pool. Further, store-dependent Ca 2+ entry was inhibited by the SOCE inhibitor, AU1 c BTP-2. Real-time reverse transcriptionpolymerase chain reaction and western blot analyses showed that both PB-EPCs and UCB-EPCs express all the molecular candidates to mediate SOCE in differentiated cells, including TRPC1, TRPC4, Orai1, and Stim1. Moreover, pharmacological maneuvers demonstrated that, as well as in differentiated endothelial cells, the signal transduction pathway leading to depletion of the intracellular Ca 2+ pool impinged on the phospholipase C=inositol-1,4,5-trisphosphate pathway. Finally, blockage of SOCE with AU1 c BTP-2 impaired PB-EPC proliferation. These findings provide the first evidence that EPCs express SOCE, which might thus be regarded as a novel target to enhance the regenerative outcome of cell-based therapy.
Introduction
E ndothelial progenitor cells (EPCs) comprise a subpopulation of bone marrow-derived mononuclear cells (MNCs) that are capable of differentiating into mature endothelial cells (ECs) and contribute to adult blood vessel formation and repair [1] . Immunophenotyping of circulating EPCs has long been a matter for debate. Such uncertainty stemmed from the observation that these cells share a profile of surface antigens (CD133, CD34, c-kit=117, VEGFR2=KDR, CXCR4) similar to that of hematopoietic stem cells [1] . However, there is now a general agreement that ''true'' endothelial progenitors may be grown in vitro from the CD45 À =CD34 þ fraction of peripheral MNCs, which are also named endothelial colony-forming cells [ECFCs] , may achieve 20-30 population doublings without obvious signs of senescence, and may retain the ability to form capillary-like structures in Matrigel [2, 3] . ECFCs differ from the colony-forming unit-ECs (CFU-ECs), which were initially regarded as endothelial in origin [2, 3] . Indeed, CFU-ECs belong to the hematopoietic lineage, retain some myeloid progenitor activity, differentiate into phagocytic macrophages and not ECs, and lack vesselforming capacity in vivo [3] . The same protocol has been employed to harvest ECFCs from the cord blood: these cells display a high proliferation potential and replate into secondary and tertiary colonies [2] . The finding that circulating EPCs traffic to sites of neovascularization, proliferate, and differentiate into ECs is consistent with the notion of adult vasculogenesis [4] . More specifically, EPCs are mobilized from bone marrow in response to local tissue ischemia or damage to replace dysfunctional ECs at the onset of severe cardiovascular disorders, such as atherosclerosis and arterial stenosis secondary to injury [5, 6] . As a consequence, EPCs play a pivotal role in restoring the supply of oxygen and nutrients to infarcted myocardium [7] , ischemic limbs [8] , and growing tumors [9] . Their regenerative potential renders EPCs particularly amenable for cell-based therapy, as discussed in several recent reviews [1, 5, [10] [11] [12] . However, because of their paucity in samples collected from peripheral blood (PB), which may be too low to exert beneficial effects, and their uncertain differentiation fate, which may be harmful for the recipient, unveiling the signal transduction pathway regulating EPC behavior is essential to improve the outcome of cell-based therapy [10, 11] . As well as PB-derived EPCs (PB-EPCs), the therapeutic potential of umbilical cord blood-derived EPCs (UCB-EPCs) has been shown in a recent study, in which the authors demonstrated that transplantation of expanded UCB-EPCs favored neovascularization in a mouse ischemic hind-limb model [13] . Similar to their peripheral counterparts, the cellular mechanisms driving UCB-EPC function are yet to be elucidated.
An increase in intracellular Ca 2þ concentration ([Ca 2þ ] i ) is the key signal in the regulation of a myriad of functions in mature ECs [14] [15] [16] [17] [18] . The elevation in [Ca 2þ ] i displayed by macrovascular ECs upon stimulation is generally biphasic and consists in an initial rise that rapidly decays to a plateau level of lower amplitude until agonist removal [18] . In more detail, ligand binding to G q=11 protein-coupled receptors (GPCRs) results in the activation of phospholipase C beta (PLC-b), which, in turn, cleaves phosphatidylinositol-4,5-bisphosphate to inositol 1,4,5-trisphosphate (InsP 3 ) and diacylglycerol (DAG) [16, 18] . DAG engages both protein kinase C and nonselective cation channels on the cellular membrane, whereas InsP 3 rapidly diffuses within the cytosol to bind to and activate the InsP 3 receptors (InsP 3 Rs) in the endoplasmic reticulum (ER). InsP 3 Rs, in turn, serve as Ca 2þ -permeable channels to release luminal stored Ca 2þ and shape the initial Ca 2þ transient [16, 18] . In ECs, as well as in most other nonexcitable (ie, not endowed with voltage-gated ion channels) cells, ER depletion causes the activation of Ca 2þ -permeable ion channels in the plasma membrane, a mechanism that has been termed store-operated Ca 2þ entry (SOCE), and sustains the following plateau phase [19, 20] . The tight link between SOCE and ER Ca 2þ content is underscored by the observation that inhibitors of the sarco-ER Ca 2þ -ATPase (SERCA), such as cyclopiazonic acid (CPA), activate Ca 2þ entry by preventing Ca 2þ -reuptake into the stores, a maneuver leading to ER depletion [21] [22] [23] . SOCE contributes to the global increase in [Ca 2þ ] i , which triggers the release of a number of vasoactive=inflammatory mediators, such as nitric oxide, prostacyclin, von Willebrand factor, platelet activating factor, tissue plasminogen activator, and tissue factor pathway inhibitor [14] . Moreover, SOCE controls the genetic program underlying EC proliferation by engaging Ca 2þ -sensitive transcription factors, including the nuclear factor of activated T-cells (NFAT) and the nuclear factor kappaB (NFkB) [19, 24, 25] . Finally, store-dependent Ca 2þ inflow governs the paracellular permeability of endothelial monolayers by triggering cytoskeleton reorganization (through myosin light chain-dependent contraction) and consequent disassembly of VE-cadherins at adherens junctions [14] . Unveiling the molecular nature of SOCE in mature ECs has engendered remarkable controversy [26] . Several lines of evidence hinted at members of the canonical transient receptor potential (TRPC) family of cation channels as prime candidates for SOCE in vascular endothelium [18] . Indeed, store-dependent Ca 2þ inflow was strongly dampened in cells lacking either TRPC1 [27] or TRPC4 [28, 29] . Conversely, a recent report proposed the stromal interaction molecule-1 (Stim1)=Orai1 pathway to mediate SOCE in ECs [19] . More specifically, Stim1 is a transmembrane ER Ca 2þ sensor that translocates in close proximity to the plasma membrane upon store depletion and activates Orai1 Ca 2þ channel to gate SOCE [22] . Although EPCs incorporate into neovessels to recapitulate endothelial functions following tissue injury or ischemia [4] , at the present time, it is unknown whether these cells are endowed with such a critical signaling pathway, that is, store-dependent Ca 2þ inflow, before differentiating into mature ECs. The aim of this article was to investigate SOCE in EPCs harvested from both PB and UCB. We provide the first evidence that SOCE occurs also in EPCs upon emptying of InsP 3 -sensitive intracellular Ca 2þ stores. Further, we show that EPCs express all the molecular candidates to mediate SOCE in mature ECs, such as TRPC1, TRPC4, Stim1, and Orai1. Finally, we demonstrate that SOCE inhibition blocks EPC proliferation. These findings gain crucial insights into the molecular mechanisms that govern EPC signaling and provide novel putative targets for genetic manipulation aimed at enhancing EPC response to angiogenic stimuli.
Materials and Methods

Isolation and cultivation of EPCs
Blood samples (40 mL) were obtained from healthy human volunteers aged from 22 to 28 years. The Institutional Review Board at ''Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation'' in Pavia approved all protocols. Informed consent was obtained according to the Declaration of Helsinki. To isolate ECFCs, MNCs were separated from either PB or UCB by density gradient centrifugation on lymphocyte separation medium for 30 min at 400 g and washed twice in endothelial basal medium with 2% FCS (EBM-2). A median of 36Â10 6 MNCs (range: 18-66) from PB and 16Â10
6 MNCs (range: 7-23) from UCB were plated on collagen-coated culture dishes (BD Biosciences) in the presence of the EC growth medium EGM-2 MV Bullet Kit (Lonza) containing EBM-2, 5% fetal bovine serum, recombinant human (rh) EGF, rhVEGF, rhFGF-B, rhIGF-1, ascorbic acid, and heparin and maintained at 378C in 5% CO 2 and humidified atmosphere. Discard of nonadherent cells was performed after 2 days; thereafter, medium was changed 3 times a week. The outgrowth of ECs from adherent MNCs was characterized by the formation of a cluster of cobblestone-appearing cells, as previously described [3] ). Whether ECFCderived colonies belonged to endothelial lineage was confirmed by staining with anti-CD31, anti-CD105, anti-CD144, anti-CD146, anti-vWf, anti-CD45, and anti-CD14 monoclonal antibodies (see b ST1
Supplemental Table S1 in Supplemental Information, available online at www.liebertonline.com) and by assessment of capillary-like network formation in an in vitro matrigel assay (see Supplemental Fig. S1c, d in Supplemental Information, available online at www.liebertonline .com), as previously described [2, 30] . More specifically, immunophenotyping of ECFC-derived cells isolated from both UCB and PB showed substantially overlapping surface pro-2 SÁ NCHEZ-HERNÁ NDEZ ET AL.
tein expression. Both UCB-and PB-derived cells showed consistent expression of endothelial proteins, whereas negligible expression of the pan-leukocyte marker CD45 was observed, confirming their belonging to the endothelial lineage (see Supplemental Table S1 in Supplemental Information). EPCs were loaded with 4 mM fura-2 acetoxymethyl ester (fura-2=AM; 1 mM stock in dimethyl sulfoxide) in PSS for AU4 c 1 h min at room temperature. After washing in PSS, the coverslip was fixed to the bottom of a Petri dish and the cells were observed using an upright epifluorescence Axiolab microscope (Carl Zeiss), usually equipped with a Zeiss X63 Achroplan objective (water-immersion, 2.0 mm working distance, 0.9 numerical aperture). EPCs were excited alternately at 340 and 380 nm, and the emitted light was detected at 510 nm. A first neutral density filter (1 or 0.3 optical density) reduced the overall intensity of the excitation light and a second neutral density filter (optical density ¼ 0.3) was coupled to the 380 nm filter to approach the intensity of the 340 nm light. A round diaphragm was used to increase the contrast. The excitation filters were mounted on a filter wheel (Lambda 10; Sutter Instrument). Custom software, working in the LINUX environment, was used to drive the camera (Extended-ISIS Camera; Photonic Science) and the filter wheel and to measure and plot on-line the fluorescence from 10 to 15 rectangular ''regions of interest'' (ROI) enclosing 10-15 single cells. Each ROI was identified by a number. As cell borders were not clearly identifiable, an ROI may not include the whole EPC or may include part of an adjacent EPC. Adjacent ROIs never superimposed. [Ca 2þ ] i was monitored by measuring, for each ROI, the ratio of the mean fluorescence emitted at 510 nm when exciting alternatively at 340 and 380 nm (shortly termed ''ratio''). An increase in [Ca 2þ ] i causes an increase in the ratio [31] . Ratio measurements were performed and plotted on-line every 3-5 s. The experiments were performed at room temperature. The human umbilical cord rings were loaded with 4 mM fura-2=AM for 4 h at room temperature and analyzed using the same equipment described above.
Solutions
RNA isolation and real-time reverse transcription-polymerase chain reaction
Total RNA was extracted from the EPCs using the QIAzol Lysis Reagent (Qiagen). Single cDNA was synthesized from RNA (1 mg) using random hexamers and M-MLV Reverse Transcriptase (Invitrogen S.R.L.). Reverse transcription was always performed in the presence or absence (negative control) of the reverse transcriptase enzyme.
b AU5
q-polymerase chain reaction (PCR) was performed in triplicate using 1 mg cDNA and specific primers (intron-spanning primers; b T1 
, and then fold changes were determined using transformation: fold increase ¼ 2
ÀDDCt ; fold decrease ¼ À2 DDCt . The sequences of the bands were checked by using the Big Dye Terminator Cycle Sequencing kit (Applied Biosystem). PCR products were also separated by agarose gel electrophoresis, stained with ethidium bromide, and acquired with the Image Master VDS (Amersham Biosciences Europe). The molecular weight of the PCR products was compared with the DNA molecular weight marker VIII (Roche Molecular Biochemicals).
Sample preparation and immunoblotting
PB-EPCs and UCB-EPCs were homogenized by using a Dounce homogenizer in a solution containing 250 mM sucrose, 1 mM ethylenediaminetetraacetic acid, 10 mM TrisHCl (pH 7.6), 0.1 mg=mL PMSF AU1 c , 100 mM b-mercaptoethanol, and Protease Inhibitor Cocktail (P8340; Sigma). The homogenates were solubilized in Laemmli buffer [34] and 20-40 mg proteins were separated on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to the Hybond-P PVDF Membrane (GE Healthcare) by electroelution. After 1 h blocking with Tris-buffered saline containing 3% bovine serum albumin and 0.1% Tween (blocking solution), the membranes were incubated for 3 h at room temperature with affinity-purified antibodies diluted 1:200 in the Tris-buffered saline and 0.1% Tween. Anti-Stim1 (sc-166840) and anti-TRPC4 (sc-15063) were obtained from Santa Cruz Biotechnology, anti-Orai1 was from Alomone Labs, and anti-TRPC1 (T8276) from SigmaAldrich.
The membranes were washed and incubated for 1 h with peroxidase-conjugated mouse, rabbit, and goat IgG (1:120,000 in blocking solution) (QED Bioscience). The bands were detected with the ECLÔ Advance western blotting detection system (GE Healthcare Europe GmbH). Control experiments were performed by using the antibody preadsorbed with a 20-fold molar excess of the immunizing peptide and by incubating the blots with nonimmune serum. BenchMark prestained protein ladders (Invitrogen) were used to estimate the molecular weights.
Protein content
Protein contents of all the samples were determined by the Bradford's method, using bovine serum albumin as a standard [35] .
Proliferation assays
A total of 1Â10 5 ECFC-derived cells (first passage) were plated in 30-mm collagen-treated dishes in EGM-2 MV medium with or without 2-20 mM b AU3 BTP-2. We chose this range after preliminary experiments, which showed no or unspecific toxic effect for lower or higher concentrations of BTP-2, respectively. Cultures were incubated at 378C (in 5% CO 2 and humidified atmosphere) and cell growth was assessed every day until confluence was reached in the control cultures (0 mM BTP-2). At this point, cells were recovered by trypsinization from all dishes and the cell number was assessed by counting in a hemocytometer. The percentage of growth inhibition by the drug was calculated by dividing the total number of cells obtained in presence of BTP-2 by the number of cells in control experiments and multiplying the ratio by 100.
Statistics
All the data have been collected from EPCs isolated from the PB of at least 3 healthy volunteers or 3 different samples of UCB. The amplitude of the peak Ca 2þ response was measured as the difference between the ratio at the peak and the mean ratio of 1 min baseline before the peak. Plateau amplitude was measured by averaging 60 s of signal at 10 min after the peak. Pooled data are given as mean AE SE and statistical significance (P < 0.05) was evaluated by the Student's t-test for unpaired observations.
As to mRNA analysis, all data are expressed as means SEM. Statistical analysis of qRT-PCR experiments was primarily performed on DCt values. The significance of the differences of the means was evaluated with 1-way ANOVA followed by Newman-Keuls's Q test or Student's t-test. All statistical tests were carried out with GraphPad Prism 4.
Chemicals
EBM and EGM-2 were purchased from Clonetics (Cell System). Fura-2=AM was obtained from Molecular Probes Europe BV. N-(4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl)-4-methyl-1,2,3-thiadiazole-5-carboxamide (BTP-2) was purchased from Calbiochem. All other chemicals were obtained from Sigma Chemical.
Results
Stimulation of SOCE by CPA-induced store emptying in EPCs harvested from PB
To assess the presence of a functional store-operated Ca 2þ inflow, we carried out fluorescence measurements of EPCs loaded with the Ca 2þ -sensitive fluorochrome, Fura-2, and exposed to CPA. CPA, a widely employed SERCA blocker [21] , prevents Ca 2þ sequestration into the stores, thus leading to their depletion and to SOCE activation [21] [22] [23] . As depicted in b F1 inflow through opened store-operated channels, which resulted in a robust increase in intracellular Ca 2þ levels (Fig.  1A, C) (Fig. 1B) . This result hinted at the presence of a resting Ca 2þ permeability that was not investigated. The store-dependent nature of CPA-elicited Ca 2þ entry into EPCs was further assessed by employing BTP-2, a specific inhibitor of SOCE [36] . Acute application of BTP-2 (20 mM) strongly inhibited CPA-dependent Ca 2þ inflow in PB-EPCs (n ¼156) (Fig. 1A) . Accordingly, 30-min preincubation with BTP-2 (20 mM) prevented SOCE in PB-EPCs (Fig.  1B, C) , whereas it did not affect the ER Ca 2þ content (Fig. 1B,  C) . Altogether, these data indicate that a functional SOCE is expressed in both PB-EPCs. Conversely, such cells lack functional voltage-gated Ca 2þ channels (VGCCs), which promote Ca 2þ inrush into excitable cells. Consistently, when PB-EPCs were exposed to high KCl extracellular solution, a protocol that may activate voltage-dependent Ca 2þ transients in ECs obtained from bovine adrenal medulla [37] , no Ca 2þ signal could be detected (n ¼ 59) (data not shown).
SOCE may be engaged by physiological stimulation in PB-EPCs
SOCE engagement following activation of GPCRs was investigated by first testing the effect of a number of vasoactive agonists that mobilize Ca 2þ from InsP 3 -sensitive intracellular stores [18] . b F2 Figure 2 shows that neither l-epinephrine (50 mM; n ¼ 51) nor acetylcholine (50 mM; n ¼ 76) evoked a detectable Ca 2þ signal in PB-EPCs, whereas both bradykinin (1-5 mM; n ¼198) and ATP (100 mM) elicited a large increase in [Ca 2þ ] i . Notably, all the ligands were applied at concentrations known to exert maximal effects on mature ECs [38] [39] [40] . ATP, but not bradykinin, evoked a clear plateau (0.069 AE 0.001; n ¼ 600) following the initial Ca 2þ peak (0.143 AE 0.003; n ¼ 593) (Fig. 2C, D) , a feature that hinted at SOCE activation. As reported in mature endothelium [18] , the [Ca 2þ ] i plateau rapidly returned to prestimulation level on agonist removal (Fig. 2D) . Therefore, we decided to employ ATP to study the physiological activation of SOCE in EPCs. The role of Ca 2þ influx during agonist stimulation was investigated by removing extracellular Ca 2þ (0Ca 2þ ) during the plateau phase. This maneuver caused Ca 2þ to decline even in the continued presence of ATP in PB-EPCs (n ¼128) ( b F3 Fig. 3A ). In accordance with these results, the plateau phase disappeared when ATP was applied in the absence of extracellular Ca 2þ in PB-EPCs (n ¼165) (Fig. 3B) . Under these conditions, the peak of the Ca 2þ increase was significantly (P < 0. 
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release and external Ca 2þ inflow. PB-EPCs were exposed to ATP (100 mM) in 0Ca 2þ to deplete intracellular stores and activate the SOCE mechanism ( F4 c Fig. 4A ). Thereafter, Ca 2þ was reintroduced in the absence of the agonist to rule out the engagement of receptor-dependent Ca 2þ permeable channels [41] , such as P 2X ionotropic receptors [42] , or second messenger-operated Ca 2þ channels [43] . Such a maneuver induced a robust increase in [Ca 2þ ] i in PB-EPCs (Fig. 4A) , thus hinting at SOCE recruitment by GPCRs. These data were supported by the BTP-2 sensitivity of Ca 2þ entry. Indeed, 30 min pretreatment with BTP-2 (20 mM) prevented ATP-dependent SOCE in PB-EPCs, whereas it did not affect the intracellular Ca 2þ release (Fig. 4B, C) . Moreover, acute perfusion of BTP-2 (50 mM) blocked ATP-induced sustained component (n ¼112) (Fig.  4D) . Finally, 30-min preincubation with BTP-2 (20 mM) strongly dampened the plateau phase of the Ca 2þ signal in PBEPCs (n ¼ 265) (Fig. 4E) GPCRs-induced Ca 2þ store depletion requires the PLC=InsP 3 pathway
In mature ECs, SOCE recruitment by GPCRs is mediated by the PLC-b=InsP 3 signaling pathway. The following experiments were carried out in 0Ca 2þ to prevent any contaminating signal from Ca 2þ entry and focus on the molecular mechanisms underlying ER Ca 2þ store depletion. To assess the effects of the selective antagonists of the PLCb=InsP 3 pathway on the same cells, ATP was bath-applied 3 times (control, experiments, washout) for 100 s at 30-min (U73122) and 10-min (caffeine) intervals. U73122 (10 mM), a widely employed PLC-b blocker [31, 45] , prevented ATPinduced [Ca 2þ ] i elevation in all 96 PB-EPCs ( b F5 Fig. 5A ). Washout of the drug led to the recovery of Ca 2þ response to ATP (Fig. 5A) . Subsequently, we assessed the effect of caffeine on intracellular Ca 2þ homeostasis. Depending on the concentration, in vascular endothelium, caffeine may both inhibit InsP 3 Rs [31, 45] and activate ryanodine receptors (RyRs) through the process of Ca 2þ -induced Ca 2þ release (CICR) [46] . When applied at 20 mM, a dose able to stimulate RyRs in rabbit aortic ECs [46] , caffeine did not elicit any detectable Ca 2þ transient (n ¼ 83) (Fig. 5B) ] i followed by a plateau of lesser magnitude, which was sustained while the agonist was present in PB-EPCs.
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( Fig. 5C ). The statistical analysis of these data has been summarized in Fig. 5D . Finally, depletion of InsP 3 Rs-sensitive store by previous addition of the SERCA inhibitor, CPA (10 mM), in absence of extracellular Ca 2þ prevented ATP-induced elevation of [Ca 2þ ] i (n ¼ 50) (not shown). Collectively, these data indicate that, as in mature ECs, the PLC-b=InsP 3 signaling pathway causes Ca 2þ store depletion, which leads to SOCE. The latter route is engaged by metabotropic P 2Y receptors when the incoming stimulus is provided by ATP. Consistently, the nonselective purinergic antagonist, suramin (300 mM) [47] , reversibly inhibited the Ca 2þ response to ATP in PB-EPCs (Fig. 5E) . Indeed, the magnitudes of the Ca 2þ peak were 0.314 AE 0.012, n ¼119, and 0.059 AE 0.005, n ¼119, in absence and presence, respectively, of the drug. Suramin is a fluorescent molecule and its application rapidly decreases the basal fluorescence ratio (Fig. 5E ) (see also 31
AU6 c
). However, the presence of the drug still allows the fluorimetric system to monitor intracellular Ca 2þ signals, as indicated by exposing the cells to bradykinin (5 mM) after suramin addition (not shown).
The mRNA encoding for putative mediators of SOCE is present in PB-EPCs
The expression of the molecular entities that have been proposed to underpin store-dependent Ca 2þ entry in mature endothelium has been investigated in PB-EPCs by employing qRT-PCR. The specific primers depicted in Table 1 have been employed to evaluate the expression of mRNAs encoding for all TRPC (TRPC1 and TRPC3-7) channels expressed in humans [48] and for the recently cloned Orai (Orai1-3) and Stim (Stim1 and Stim2) genes [22, 34] . TRPC1, TRPC4, Orai1, Orai2, Orai3, Stim1, and Stim2 transcripts were readily detectable in PB-EPCs ( b F6 Fig. 6A ), whereas there were no significant amount of mRNA for TRPC3, TRPC5, TRPC6, and TRPC7. Single bands of the expected size of cDNA fragments were amplified and the results of agarose gel electrophoresis of representative PCR products are shown in Fig. 6A . Negative controls were performed by omitting the reverse transcriptase (not shown). The comparison of DCt values of mRNA obtained by qRT-PCR in PB-EPCs showed that Orai1 transcript was significantly higher than Orai2, Orai3, Stim1, Stim2, and TRPC1 and that TRPC4 transcript was the lowest (P < 0.05, ANOVA followed by Newman-Keuls' Q test) (Fig. 6B) .
SOCE is expressed in EPCs isolated from UCB
To assess SOCE expression in UCB-EPCs, the latter underwent the Ca 2þ add-back protocol upon exposure to CPA (10 mM) in 0Ca 2þ . As illustrated in b F7 (Fig. 7A) . As observed in their peripheral counterparts, UCB-EPCs displayed a biphasic Ca 2þ response to ATP (100 mM) (Fig. 7B) . In these cells, the amplitudes of the transient Ca 2þ rise and the sustained components were, respectively, 0.162 AE 0.004 (n ¼ 224) and 0.064 AE 0.002 (n ¼ 216). Both values are significantly (P < 0.05) smaller than those (see above) measured in PB-EPCs. As observed in the latter, when external Ca 2þ was omitted during the plateau phase, [Ca 2þ ] i returned to the resting levels in all 130 cells (Fig. 7B) . Consistent with this finding, when ATP was administered in absence of extracellular Ca 2þ , the cells exhibited only the transient peak without the sustained component (Fig. 7C) . As in PB-EPCs, the height of the Ca 2þ response to ATP was significantly (P < 0.05) higher in 0Ca 2þ (0.164 AE 0.006; n ¼132) than in PSS (0.207 AE 0.007; n ¼103). Notably, the plateau phase of ATPelicited Ca 2þ signal was strongly inhibited by BTP-2 (50 mM) in 131 cells (Fig. 7D) . Collectively, these results indicate that also UCB-EPCs express a SOCE pathway that may be engaged following physiological stimulation of GPCRs. The qRT-PCR analysis revealed that, in addition to the transcripts found in PB-EPCs, UCB-EPCs express TRPC3 ( b F8   Fig. 8A ). Single bands of the expected size of cDNA fragments were amplified and the results of agarose gel electrophoresis of representative PCR reaction products are shown in Fig. 8A . Negative controls were performed by omitting the reverse transcriptase (not shown). The comparison of DCt values of the Ca 2þ signal pathway mRNA obtained by qRT-PCR showed that TRPC1, TRPC3, TRPC4, Orai2, and Stim1 transcripts were significantly lower than Orai1, Orai3, and Stim2 (P < 0.01, ANOVA followed by Newman-Keuls's Q test) (Fig. 8B) . Finally, when comparing the Ca 2þ channel gene expression in the 2 cell populations, we found that Orai1, Orai3, and Stim2 levels were 6-, 22-, and 46-fold higher in UCB-EPCs, respectively ( b F9 
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levels were 18-and 12-fold higher in PB-EPCs, respectively, whereas TRPC1 and TRPC4 were similar (Fig. 9 ).
SOCE-related proteins are expressed in both PB-and UCB-EPCs
Western blot analysis of Orai1, Stim1, TRPC1, and TRPC4 expression was conducted using affinity-purified antibodies. As observed for the RNA transcripts, all these proteins were detected in both PB-EPCs and UCB-EPCs ( F10 c Fig. 10 ). Immunoblots showed major bands of about 33, 110, 110, and 100 kDa for Orai1, Stim1, TRPC1, and TRPC4, respectively. The molecular sizes were similar to those reported in the literature [19, 49] . When the antibodies were preadsorbed with large amounts of the immunizing peptide or the antibodies substituted with nonimmune serum, the protein bands completely disappeared, thus indicating the specificity of the reaction. Along with the qRT-PCR analysis, these data demonstrate that both PB-and UCB-EPCs possess the molecular machinery that has been associated with SOCE in mature ECs.
SOCE drives EPC proliferation
To assess the physiological outcome of SOCE, we focused on its involvement in EPC replication, as such a pathway may regulate the growth of mature ECs [19] . The proliferation assay was conducted on PB-EPCs. As shown in b T2 Table 2 , BTP-2 inhibited cell growth in a dose-dependent manner (2-20 mM) . None of the cultures carried on in the presence of BTP-2 reached confluence at the time (3 days) reached by control cultures. Confluence was never reached by BTP-2-exposed cells at longer incubation and cells usually began detaching and dying after 5-6 days of culture. Therefore, SOCE stands as a novel player in the signaling network underlying EPC proliferation and provides an additional target to enhance the outcome of cell-based therapy.
Discussion
EPCs are mobilized from BM to promote neovascularization and favor reendothelialization following vascular damage [1, 4, 11] . This observation prompted the injection of 
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exogenous EPCs, harvested from both peripheral and UCB, as a novel therapeutic strategy to treat ischemic diseases [1, 13] . Indeed, EPCs home to sites of tissue regeneration and contribute to neovascularization by acquiring an endothelial phenotype and being incorporated into neovessels [1, 4] . In mature ECs lining the lumen of blood vessels, SOCE activation by GPCRs is central to the control of a wide number of functions, including proliferation, secretion, vascular permeability, and regulation of blood pressure [14] [15] [16] [17] [18] [19] 24] . In the view of such a relevant role, it was worth investigating whether EPCs possess the SOCE pathway as well. Our results provide the first evidence that store-dependent Ca 2þ inflow is present in both EPCs flowing in PB and EPCs harvested from UCB. Further, both PB-EPCs and UCB-EPCs express all the molecular candidates to mediate SOCE in mature ECs, that is, TRPC1, TRPC4, and Stim1=Orai1. We finally show that the signal transduction cascade involved in SOCE opening in differentiated endothelium, that is, ER Ca 2þ store depletion by InsP 3 Rs activation, is also present in EPCs. Several lines of evidence indicate that GPCRs recruit SOCE by emptying the ER reservoir via PLC-b=InsP 3 signaling in EPCs. First, ligand (ie, ATP)-induced depletion of the intracellular Ca 2þ pool in 0Ca 2þ is a signal sufficient to activate Ca 2þ inflow on Ca 2þ readdition in the absence of agonist. As widely reported in the literature [21, 23, 41] , this feature implies that Ca 2þ entry occurs independently on receptor occupancy and does not rely on intracellular second messengers, such as InsP 3 and DAG. When the agonist is withdrawn in the continuous presence of Ca 2þ (Fig. 2D ), [Ca 2þ ] i recovers to the baseline as InsP 3 synthesis terminates such that InsP 3 Rs close. As a consequence of the rapid interruption of Ca 2þ efflux from ER, the intracellular Ca 2þ pool refills and SOCE is inactivated [39, 50, 51] . On the other hand, exposure to ATP in the absence of extracellular Ca 2þ leads to a transient Ca 2þ signal (Fig. 4A) , as most of Ca 2þ released from InsP 3 Rs is extruded by plasma membrane transporters, such as Na ] i observed on Ca 2þ replenishment to the bath even in the absence of agonist [21, 23, 41, 50, 51] . Accordingly, passive depletion of the ER Ca 2þ content with CPA led to the opening of Ca 2þ -permeable channels on the plasma membrane, which is the hallmark of SOCE [21, 23] , in both 
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PB-EPCs and UCB-EPCs. Second, BTP-2, the hitherto most powerful and selective inhibitor of store-dependent Ca 2þ inflow [36] , abrogated CPA-and P 2Y receptor-induced Ca 2þ inflow in both cell types. Third, U73122, a widely employed pharmacological PLC blocker [31] , strongly hindered ATP-elicited depletion of the ER Ca 2þ pool. This finding is supported by a recent study that reported the expression of PLC-b2 in mice UCB-EPCs at both mRNA and protein levels [52] . Fourth, low doses of caffeine, which have long been known to antagonize InsP 3 -gated channels in several cell types, including rat cardiac microvascular ECs [31,45 and references therein], significantly reduced ATP-dependent Ca 2þ mobilization from ER. Further, higher doses of caffeine, which stimulate RyRs to release Ca 2þ via the so-called CICR, did not trigger any Ca 2þ increase under control conditions. This result suggests either that functional RyRs are not expressed in EPCs or that resting Ca 2þ levels are too low to enable the drug to sensitize RyRs [53] . Therefore, although our data indicate that RyRs are unlikely to participate in the signal transduction pathway leading to SOCE, further analyses are necessary to rule out their expression in EPCs. Notably, we found that bradykinin, which may promote Ca 2þ signals via the G-protein-coupled B2 receptor [54] , elicited a robust InsP 3 -dependent Ca 2þ release, but not storedependent Ca 2þ entry (Fig. 3C ). This feature, however, is not surprising when considering that partial dissociation between Ca 2þ mobilization and SOCE activation may occur in several cells, including rat basophilic leukemia cells [55] . As reviewed in ref. [23] , it has been suggested that 2 distinct InsP 3 -regulated Ca 2þ stores exist within the ER: one mainly responsible for Ca 2þ release and another tightly coupled to SOCE. According to Parekh and Penner [56] , the InsP 3 -sensitive subcompartment devoted to the gating of store-operated channels is likely to lie in close proximity to the plasma membrane. It is, therefore, conceivable that, in human EPCs, ATP, but not bradykinin, engages such a pool and leads to store-dependent Ca 2þ inflow. The same feature is likely to explain why SOCE amplitude is significantly higher in CPArather than ATP-treated cells (compare Fig. 1C with Fig. 4C ). Indeed, CPA might deplete all the InsP 3 -dependent pool that is tightly coupled to plasmalemmal channels, whereas only a fraction of such a reservoir may be recruited by ATP [23, 56] .
The report of a functional SOCE pathway in both PB-EPCs and UCB-EPCs has 2 remarkable implications: (1) unlike other components of the endothelial signaling toolkit, such as muscarinic receptors or RyRs, this route is already expressed in immature cells, and consequently, (2) store-dependent Ca 2þ inflow stands as a novel candidate among the mechanisms regulating EPC mobilization, proliferation, and homing.
The molecular underpinnings of SOCE in mature human endothelium, as well as in other cell types, include several candidates, such as TRPC1, TRPC4, and Stim1=Orai1 [19, 20, [27] [28] [29] . Earlier studies provided the evidence that the molecular make-up of the Ca 2þ channels gated by a drop in ER Ca 2þ content in ECs comprised both TRPC1 and TRPC4, the latter being the subunit essential for coupling store depletion to channel activation [20, [27] [28] [29] . These data have been recently challenged by Trebak's group, who showed that small interference RNAs (siRNAs) targeted against either Stim1 or Orai1, but not against TRPC1 and TRPC4, inhibited SOCE in human umbilical vein ECs (HUVECs) [19] . This apparent discrepancy might arise from the well-known heterogeneity in the endothelial phenotype [57] , so that ECs located in different vascular beds might mediate SOCE through distinct mechanisms [57, 58] . Notably, qRT-PCR has revealed mRNA encoding for TRPC1=TRPC4 and Stim1= Orai1 in PB-EPCs and UCB-EPCs. The abundance of relative gene expression for these proteins was Orai1 > Stim1 ¼ TRPC1 > TRPC4 in PB-EPCs and Stim1 ¼ TRPC4 > TRPC1 Orai1 in UCB-EPCs. When comparing the expression of such transcripts between the 2 cell types, we found that Orai1 and Stim1 are more abundant in PB-EPCs and UCBEPCs, respectively, whereas TRPC1 and TRPC4 are expressed at the same level in both EPC types. Such a result cannot explain the fluorimetric measurements (ie, SOCE was higher in PB-EPCs) because of the tight stoichiometric coupling among the molecular candidates of SOCE [22, 36] . Western blot experiments confirmed that all the transcripts encoding TRPC1=TRPC4 and Stim1=Orai1 are translated into proteins of the expected molecular mass in both PBEPCs and UCB-EPCs. These data are consistent with the presence of all the putative mediators of store-operated Ca 2þ channels in mature ECs. Therefore, siRNA experiments are required to unveil the molecular identity of storedependent Ca 2þ inflow in EPCs. The latter expressed also 
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Stim2 and Orai2-3, which have been involved in SOCE in differentiated cells [22, 36] . Stim2 has been reported to control the basal Ca 2þ leak in several cell types [59] , including HUVECs, and might regulate the resting Ca 2þ inflow that we observed upon removal of external Ca 2þ in a fraction of EPCs. As to Orai2 and Orai3, they have been also found in HUVECs [19] and might contribute to SOCE by forming heteromultimers with Orai1 in heterologous expression systems [22, 36] . Nevertheless, their participation to GPCRinduced store-dependent Ca 2þ entry in vascular endothelium is unlikely [19] . It is worth noting that we could not detect any transcript for other members of the TRPC family that are known to modulate endothelial function [17, 60] . Indeed, unlike ECs from human arteries [60] and human microvessels [61, 62] , no transcripts of TRPC2, TRPC3, TRPC5, TRPC6, and TRPC7 were found by either quantitative or qualitative RT-PCR in PB-EPCs, whereas only TRPC3 was detected in UCB-EPCs. Preliminary experiments confirmed that the latter channel is also expressed at protein level. This feature is rather relevant when considering that peripheral EPCs may differentiate into mature ECs on mobilization from bone marrow. For instance, TRPC3, TRPC6, and TRPC7 mediate VEGF-triggered Ca 2þ influx following an increase in the levels of the intracellular second messenger, DAG [17, 60] , in ECs isolated from several vascular beds [61, 62] . It is, therefore, conceivable to assume that EPCs express the mRNA encoding for these channels when they are incorporated within the foci of neovascularization, where they acquire a mature phenotype and are exposed to site-specific environmental cues [57] . In agreement with this hypothesis, human cardiac progenitor cells do not express RyRs, although the latter drives Ca 2þ cycling in differentiated cardiomyocytes [63] . Further, EPCs harvested from both peripheral and cord blood manifest a number of endothelial markers, such as CD31 and vascular cell adhesion molecule-1, and the ability to incorporate DiIacetylated low-density lipoprotein, only following in vitro differentiation [2] . The same feature is likely to apply also for muscarinic and catecholamine receptors, which trigger intracellular Ca 2þ elevations in mature ECs [18, 39, 40] , but not in PB-EPCs. Similarly, voltage-dependent Ca 2þ transients have been detected in bovine adrenal medulla capillary ECs [37] , whereas they are absent in PB-EPCs. In this view, it is predictable that the reported effect of benidipine, a dihydropyridine Ca 2þ channel blocker, on the differentiative outcome of mice PB-EPCs is not due to selective 
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inhibition of Ca 2þ entry [64] . This feature concurs with the notion that benidipine stimulates EPC differentiation by activating the phosphoinositide-3 kinase (PI3K)=Akt pathway [64] .
It has long been known that Ca 2þ entry is a key regulator of endothelial proliferation and migration [16] [17] [18] [19] . For instance, knocking-down either Stim1 or Orai1, which mediates SOCE in HUVECs, inhibited EC proliferation and caused cell cycle arrest at S and G2=M phases [19] . In addition, either reduction of extracellular Ca 2þ or inhibition of plasmalemmal Ca 2þ channels have been repeatedly shown to prevent cell growth and replication [16, 65] . This feature also applies to immature cells, as blockage of SOCE dramatically impairs PB-EPC growth. Ca 2þ entry may be translated into a mitogenic signal by direct binding of the ion to Ca 2þ -dependent targets or by Ca 2þ binding to intracellular decoders such as calmodulin (CaM) and its downstream targets, including CaM kinase (CaMK) and calcineurin [16, 17] . The recruitment of the CaM=CaMK pathway is crucial to cell cycle progression through G1 and mitosis by regulating the activation of several cyclin-dependent kinases (cdk), such as cdk2 and cdk4, whereas calcineurin controls the transcription factors that promote the G1=S transition, including cAMP-responsive element binding protein 1 and NFAT [16, 65] . The finding that SOCE governs EPC proliferation highlights a novel alternative target to enhance the regenerative outcome of cell-based therapy. This latter approach mainly relies on 2 critical parameters: (1) EPC homing to ischemic organs and (2) EPC incorporation into newly growing vessels, proliferation, and differentiation into mature ECs [10] [11] [12] . Therefore, once established the molecular machinery underlying SOCE in EPCs, transfecting autologous cells with genes encoding for the identified channels could be instrumental to augment EPC number and improve neovascularization. Consistent with this hypothesis, recruitment of PLC-b2 by the insulin-like growth factor 2 (IGF2) receptor is essential to ensure proper UCB-EPC homing to sites of hind-limb ischemia [52] . Further, CD133
þ hematopoietic stem and progenitor cells isolated from PB and exposed to SDF-1a displayed a significantly reduced motility in a 3-dimensional collagen matrix migration assay upon pretreatment with BTP-2 [66] . In addition, SOCE-dependent Ca 2þ signaling has been shown to drive the differentiation process of a number of both embryonic and adult stem cells [63, [67] [68] [69] . More specifically, SOCE inhibition prevented H19-7 hippocampal neuronal cells and osteoclast precursor cells from adopting their mature phenotype [68, 69] . Indeed, store-dependent Ca 2þ inflow may regulate the pattern of gene expression by selectively engaging a number of Ca 2þ -sensitive transcription factors, such as the nuclear factor of activated T-cells and nuclear factor-kappa B [16, 17] . It will be interesting to assess whether downregulating SOCE will prevent EPC differentiation into mature ECs.
In conclusion, the present study provides the first evidence that both PB-EPCs and UCB-EPCs express storedependent Ca 2þ channels. In addition, PB-EPCs are endowed with both TRPC1=TRPC4 and STIM1=Orai1, which represent the most plausible molecular candidates to mediate SOCE in vascular endothelium. Finally, SOCE inhibition blocks PB-EPC proliferation, a finding that places such a pathway in the signaling network that controls EPC behavior [70] . Future work will be devoted to unveil the molecular underpinnings of SOCE to outline novel targets for EPC-based therapy. 
